Synthego is a pioneering force in the biotechnology industry, dedicated to advancing the frontiers of CRISPR cell and gene therapies through cutting-edge CRISPR technology and expertise. Our mission is to provide unparalleled access to best-in-class CRISPR solutions at scale, empowering agility in life science research and development from discovery through clinical trials. From streamlined approaches to licensing through full technical and regulatory support from our industry-leading experts, Synthego is enabling greater access to CRISPR technology driving to improved outcomes in patient therapeutic treatments.
With its technologies cited in hundreds of peer-reviewed publications and utilized by thousands of commercial and academic researchers and therapeutic drug developers, Synthego is at the forefront of innovation, enabling the next generation of medicines by delivering genome editing at an unprecedented scale.
At Synthego, our mission is to provide unparalleled access to CRISPR solutions at scale, empowering applications from discovery to the clinic.
With our sights firmly set on bridging the gap between genomic discoveries and clinical applications, our vision is to accelerate the therapeutic development process with best-in-class CRISPR solutions, simplified licensing & expert guidance, driving the adoption and success of CRISPR-based therapies to benefit all patients.
At Synthego, we're driven by a fusion of engineering and scientific excellence, as our core.
Our eclectic team boasts seasoned experts from the life science, biotech, pharmaceutical, and manufacturing sectors.
We thrive on collaboration with visionary individuals who not only have a track record of significant achievements but are also passionately pioneering the next breakthroughs in therapies aimed at the eradication of diseases.
CEO
Chief Legal Officer
Chief Commercial Officer
Chief Operating Officer
Chief of Staff
VP, Sales
VP, Technology
VP, Marketing
Synthego really stands out because I'm not sure if there are many others that can offer screening scale, research use guides for your lead discovery, medium to large scale RUO guides for your preclinical and pharmacology studies, and ultimately larger scale GLP Tox and clinical grade material for early and hopefully ultimately late phase trials.
Synthego’s product allows us to quickly evaluate, in a cost-effective manner, the best guide RNA to stimulate genome editing, including by homologous recombination, in therapeutically relevant human stem cells and primary human T cells.
Curious about base editing but not sure where to begin? We’ll break it down step by step, making it easy to follow and apply!
The CRISPR gene therapy regulatory space is changing rapidly. In this blog, we’re covering the latest cell and gene therapy news, including updated FDA guidances.
New CRISPR therapies are undergoing development for genetic disorders, cancer, and infectious diseases, at all stages of the clinical workflow. We know it can be tough to keep up with...
Cart
Account
Your Orders
Sign In